Investor Seeks Appointment As Lead Plaintiff In Securities Class Action
(January 19, 2016, 12:22 PM EST) -- TRENTON, N.J. — A shareholder on Dec. 21 moved for consolidation of four securities class action lawsuits and for appointment as lead plaintiff and appointment of lead counsel in New Jersey federal court, arguing that it has the largest financial stake in the litigation and has met all statutory and procedural requirements to serve as lead plaintiff (Laura Potter v. Valeant Pharmaceuticals International Inc., et al., No. 15-7658, D. N.J.).
(Motion for consolidation and appointment of lead plaintiff and lead counsel available. Document #57-160120-508B.)